Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Open-Label, Multi-center Study of AL101 in Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations

Next Previous
Trial Profile

A Phase 2, Open-Label, Multi-center Study of AL101 in Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 05 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Osugacestat (Primary)
  • Indications Adenoid cystic carcinoma
  • Focus Therapeutic Use
  • Acronyms ACCURACY
  • Sponsors Ayala Pharmaceuticals

    • Most Recent Events

    • 11 Dec 2023 Status changed from active, no longer recruiting to completed.
    • 24 Oct 2023 Final results from this trial and a meta-analysis of clinical outcomes with other clinical trials presented at the 48th European Society for Medical Oncology Congress
    • 01 Aug 2023 According to an Ayala Pharmaceuticals media release, data from this trial will be presented at the European Society for Molecular Oncology (ESMO) Congress 2023.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top